Veritone (VERI) 10-Q 5 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2021	Jul. 30, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Trading Symbol	VERI
Entity Registrant Name	Veritone, Inc.
Entity Central Index Key	0001615165
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-38093
Entity Tax Identification Number	47-1161641
Entity Address, Address Line One	1515 Arapahoe St.
Entity Address, Address Line Two	Tower 3, Suite 400
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	888
Local Phone Number	507-1737
Entity Common Stock, Shares Outstanding		32,874,492
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 120,627	$ 114,817
Accounts receivable, net	19,518	16,666
Expenditures billable to clients	20,783	18,365
Prepaid expenses and other current assets	8,944	6,719
Total current assets	169,872	156,567
Property, equipment and improvements, net	479	2,354
Intangible assets, net	8,587	10,744
Goodwill	6,904	6,904
Long-term restricted cash	855	855
Other assets	230	230
Total assets	186,927	177,654
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	16,174	15,632
Accrued media payments	68,266	55,874
Client advances	7,638	6,496
Other accrued liabilities	12,633	10,246
Total current liabilities	104,711	88,248
Other non-current liabilities	1,989	1,196
Total liabilities	106,700	89,444
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 32,870,767 and 31,799,354 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	33	32
Additional paid-in capital	403,768	368,477
Accumulated deficit	(323,647)	(280,365)
Accumulated other comprehensive income	73	66
Total stockholders' equity	80,227	88,210
Total liabilities and stockholders' equity	$ 186,927	$ 177,654

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	32,870,767	31,799,354
Common stock, shares outstanding	32,870,767	31,799,354

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenue	$ 19,206	$ 13,268	$ 37,501	$ 25,172
Operating expenses:
Cost of revenue	5,231	3,763	10,054	7,013
Sales and marketing	5,253	4,932	11,680	9,861
Research and development	4,646	3,440	9,606	7,086
General and administrative	15,644	11,343	47,187	22,886
Amortization	1,079	1,346	2,157	2,694
Total operating expenses	31,853	24,824	80,684	49,540
Loss from operations	(12,647)	(11,556)	(43,183)	(24,368)
Other expense, net	(13)	(235)	(22)	(104)
Loss before provision for income taxes	(12,660)	(11,791)	(43,205)	(24,472)
Provision for income taxes	55	2	77	5
Net loss	$ (12,715)	$ (11,793)	$ (43,282)	$ (24,477)
Net loss per share:
Basic and diluted	$ (0.39)	$ (0.43)	$ (1.33)	$ (0.91)
Weighted average shares outstanding:
Basic and diluted	32,741,356	27,117,432	32,458,269	26,945,297
Comprehensive loss:
Net loss	$ (12,715)	$ (11,793)	$ (43,282)	$ (24,477)
Foreign currency translation gain, net of income taxes		1	7	5
Total comprehensive loss	$ (12,715)	$ (11,792)	$ (43,275)	$ (24,472)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]
Beginning balance at Dec. 31, 2019	$ 47,411	$ 26	$ 279,828	$ (232,489)	$ 46
Beginning balance, shares at Dec. 31, 2019		25,670,737
Common stock offerings, net	6,006	$ 2	6,004
Common stock offerings, net, shares		1,491,317
Common stock issued under employee stock plans, net	140		140
Common stock issued under employee stock plans, net, shares		199,942
Stock-based compensation expense	8,587		8,587
Exercise of warrants	2,100	$ 2,100	2,100
Exercise of warrants, shares		154,311
Issuance of warrants	308		308
Net loss	(24,477)			(24,477)
Other comprehensive gain	5				5
Ending balance at Jun. 30, 2020	40,080	$ 28	296,967	(256,966)	51
Ending balance, shares at Jun. 30, 2020		27,516,307
Beginning balance at Dec. 31, 2019	47,411	$ 26	279,828	(232,489)	46
Beginning balance, shares at Dec. 31, 2019		25,670,737
Net loss	(47,876)
Ending balance at Dec. 31, 2020	88,210	$ 32	368,477	(280,365)	66
Ending balance, shares at Dec. 31, 2020		31,799,354
Beginning balance at Mar. 31, 2020	42,272	$ 27	287,368	(245,173)	50
Beginning balance, shares at Mar. 31, 2020		27,074,372
Common stock offerings, net	3,022	$ 1	3,021
Common stock offerings, net, shares		199,109
Common stock issued under employee stock plans, net	39		39
Common stock issued under employee stock plans, net, shares		88,515
Stock-based compensation expense	4,131		4,131
Exercise of warrants	2,100		2,100
Exercise of warrants, shares		154,311
Issuance of warrants	308		308
Net loss	(11,793)			(11,793)
Other comprehensive gain	1				1
Ending balance at Jun. 30, 2020	40,080	$ 28	296,967	(256,966)	51
Ending balance, shares at Jun. 30, 2020		27,516,307
Beginning balance at Dec. 31, 2020	88,210	$ 32	368,477	(280,365)	66
Beginning balance, shares at Dec. 31, 2020		31,799,354
Common stock issued under employee stock plans, net	4,794	$ 1	4,793
Common stock issued under employee stock plans, net, shares		803,367
Common stock issued for services	250		250
Common stock issued for services, shares		15,828
Stock-based compensation expense	27,969		27,969
Exercise of warrants	2,279	$ 2,279	2,279
Exercise of warrants, shares		252,218
Net loss	(43,282)			(43,282)
Other comprehensive gain	7				7
Ending balance at Jun. 30, 2021	80,227	$ 33	403,768	(323,647)	73
Ending balance, shares at Jun. 30, 2021		32,870,767
Beginning balance at Mar. 31, 2021	85,793	$ 33	396,619	(310,932)	73
Beginning balance, shares at Mar. 31, 2021		32,676,286
Common stock issued under employee stock plans, net	540		540
Common stock issued under employee stock plans, net, shares		194,481
Common stock issued for services	131		131
Stock-based compensation expense	6,478		6,478
Net loss	(12,715)			(12,715)
Ending balance at Jun. 30, 2021	$ 80,227	$ 33	$ 403,768	$ (323,647)	$ 73
Ending balance, shares at Jun. 30, 2021		32,870,767

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss			$ (43,282)	$ (24,477)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			2,410	3,206
Issuance of warrants				102
Loss on disposal of fixed assets			1,894
Loss on sublease			1,211
Change in fair value of warrant liability		$ 202		200
Provision for doubtful accounts			5	213
Stock-based compensation expense	$ 6,609	4,131	28,219	8,587
Changes in assets and liabilities:
Accounts receivable			(2,857)	(3,453)
Expenditures billable to clients			(2,418)	7,109
Prepaid expenses and other assets			(2,218)	(363)
Accounts payable			542	3,484
Accrued media payments			12,392	5,133
Client advances			1,142	(4,619)
Other accrued liabilities			2,387	2,193
Other liabilities			(418)	(92)
Net cash used in operating activities			(991)	(2,777)	$ 1,433	$ (30,432)
Cash flows from investing activities:
Proceeds from the sale of equipment				56
Capital expenditures			(272)	(30)
Net cash (used in) provided by investing activities			(272)	26
Cash flows from financing activities:
Proceeds from common stock offerings, net				6,527
Proceeds from loan				6,491
Repayment of loan				(6,491)
Proceeds from the exercise of warrants			2,279	2,100
Proceeds from issuances of stock under employee stock plans, net			4,794	140
Net cash provided by financing activities			7,073	8,767
Net increase in cash and cash equivalents and restricted cash			5,810	6,016
Cash and cash equivalents and restricted cash, beginning of period			115,672	44,920	44,920
Cash and cash equivalents and restricted cash, end of period	$ 121,482	$ 50,936	$ 121,482	$ 50,936	$ 115,672	$ 44,920

Description of Business

Description of Business	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Description of Business	NOTE 1. DESCRIPTION OF BUSINESS Description of Business Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, collectively, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARE TM The Company also offers cloud-native digital content management solutions and content licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content. In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds TM In July 2021, the Company announced its entry into a definitive agreement to acquire PandoLogic Ltd., a company incorporated under the laws of the state of Israel (“Pandologic”), pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Melisandra Ltd., a company incorporated under the laws of the State of Israel and a wholly-owned subsidiary of the Company (“Merger Sub”), and Shareholder Representative Services, LLC, a Colorado limited liability company, solely in its capacity as the representative of the Securityholders and COP Participants. See Note 10 for further details on the Merger Agreement.

Presentation and Summary of Sig

Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Presentation and Summary of Significant Accounting Policies	NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 5, 2021. Interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2021. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three and six month periods presented are unaudited. The December 31, 2020 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements. Reclassifications Amortization expense, which was presented in prior year periods within cost of revenue, sales and marketing, research and development, and general and administrative operating expenses, has been reclassified and is presented as a single separate line item in operating expenses. Gross profit, which was previously reflected in the statement of operations and comprehensive loss, is no longer presented. Additionally, cost of revenue, which was presented in prior periods within gross profit, is now presented as an operating expense. The Company believes that this presentation more accurately reflects the Company’s cost of revenue and operating expenses. These reclassifications had no effect on reported net loss. Liquidity and Capital Resources During the years ended December 31, 2020 and 2019, the Company generated cash flows from operations of $1,433 and negative cash flows from operations of $30,432, respectively, and incurred net losses of $47,876 and $62,078, respectively. In the six months ended June 30, 2021, the Company generated negative cash flows from operations of $991 and incurred a net loss of $43,282. The Company expects to continue to generate net losses for the foreseeable future as it makes significant investments in developing and selling its aiWARE SaaS solutions. Management believes that the Company’s existing balances of cash and cash equivalents, which totaled $120,627 as of June 30, 2021, will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Such financing may not be available on terms favorable to the Company or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired. Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to revenue recognition, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions. Significant Customers One individual customer accounted for 10% of the Company’s net revenues for the three months ended June 30, 2021. six months ended June 30, 2020 or the six months ended June 30, 2021. Remaining Performance Obligations As of June 30, 2021, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $4,668, approximately 71% of which the Company expects to recognize as revenue over the next twelve months, and the remainder thereafter. This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations. Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2020. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes and early adoption is permitted

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Net Loss Per Share	NOTE 3. NET LOSS PER SHARE The following table presents the computation of basic and diluted net loss per share: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Numerator Net loss $ (12,715 ) $ (11,793 ) $ (43,282 ) $ (24,477 ) Denominator Weighted-average common shares outstanding 32,756,357 27,135,107 32,475,448 26,964,717 Less: Weighted-average shares subject to repurchase (15,001 ) (17,675 ) (17,179 ) (19,420 ) Denominator for basic and diluted net loss per share attributable to common stockholders 32,741,356 27,117,432 32,458,269 26,945,297 Basic and diluted net loss per share $ (0.39 ) $ (0.43 ) $ (1.33 ) $ (0.91 ) The Company reported net losses for all periods presented and, as such, all potentially dilutive shares of common stock would have been antidilutive for such periods. The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Common stock options and restricted stock units 9,948,564 10,171,737 10,110,820 9,976,772 Warrants to purchase common stock 520,112 1,674,387 579,311 1,485,769 10,468,676 11,846,124 10,690,131 11,462,541

Financial Instruments

Financial Instruments	6 Months Ended
	Jun. 30, 2021
Investments All Other Investments [Abstract]
Financial Instruments	NOTE 4. FINANCIAL INSTRUMENTS Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs that may be used to measure fair value. Level 1 and Level 2 are considered observable and Level 3 is considered unobservable, as follows: • Level 1—quoted prices (unadjusted) in active markets for identical assets or liabilities; • Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or • Level 3—unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Cash and Cash Equivalents The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of June 30, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 52,602 $ — $ 52,602 $ 52,602 Level 1: Money market funds 68,025 — 68,025 68,025 Total $ 120,627 $ — $ 120,627 $ 120,627 As of December 31, 2020, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 44,795 $ — $ 44,795 $ 44,795 Level 1: Money market funds 70,022 — 70,022 70,022 Total $ 114,817 $ — $ 114,817 $ 114,817 Stock Warrants All of the Company’s outstanding stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using either a probability weighted expected return model, the Monte Carlo simulation model or the Black-Scholes option-pricing model. These models incorporate contractual terms, maturity, risk-free interest rates and volatility. The value of the Company’s stock warrants would increase if a higher risk-free interest rate was used, and would decrease if a lower risk-free interest rate was used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist.

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	6 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Net	NOTE 5. GOODWILL AND INTANGIBLE ASSETS, NET Goodwill The carrying amount of goodwill was $6,904 as of June 30, 2021 and December 31, 2020. Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: June 30, 2021 December 31, 2020 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.9 $ 3,582 $ (3,437 ) $ 145 $ 3,582 $ (3,357 ) $ 225 Licensed technology 0.3 500 (458 ) 42 500 (375 ) 125 Developed technology 2.2 9,600 (5,440 ) 4,160 9,600 (4,480 ) 5,120 Customer relationships 2.2 9,300 (5,270 ) 4,030 9,300 (4,340 ) 4,960 Noncompete agreements 1.1 800 (590 ) 210 800 (486 ) 314 Total 2.1 $ 23,782 $ (15,195 ) $ 8,587 $ 23,782 $ (13,038 ) $ 10,744 The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2021: 2021 (6 months) $ 2,104 2022 3,963 2023 2,520 Total $ 8,587

Consolidated Financial Statemen

Consolidated Financial Statements Details	6 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Consolidated Financial Statements Details	NOTE 6. CONSOLIDATED FINANCIAL STATEMENTS DETAILS Consolidated Balance Sheets Details Cash and cash equivalents As of June 30, 2021 and December 31, 2020, the Company had cash and cash equivalents of $120,627 and $114,817, respectively, including $48,226 and $40,052, respectively, of cash received from advertising clients for future payments to vendors. Accounts Receivable, Net Accounts receivable consisted of the following: As of June 30, December 31, 2021 2020 Accounts receivable — $ 15,380 $ 12,641 Accounts receivable — 4,221 4,143 19,601 16,784 Less: allowance for doubtful accounts (83 ) (118 ) Accounts receivable, net $ 19,518 $ 16,666 The amount that the Company invoices and collects from advertising clients includes the cost of the advertisements placed for them with media vendors and the amount of the commission earned by the Company. The average commission earned by the Company is less than 15% of the total amount invoiced and collected from the advertising clients. Property, Equipment and Improvements, Net Property, equipment and improvements, net consisted of the following: As of June 30, December 31, 2021 2020 Property and equipment $ 1,899 $ 2,365 Leasehold improvements 78 2,899 1,977 5,264 Less: accumulated depreciation (1,498 ) (2,910 ) Property, equipment and improvements, net $ 479 $ 2,354 During the six months ended June 30, 2021, in connection with the sublease of its former corporate office space located in Costa Mesa, California, the Company wrote-off approximately $3,559 in property and equipment and leasehold improvements and recorded a net loss on disposal of $1,894. Depreciation expense was $78 and $253 for the three and six months ended June 30, 2021, respectively. Depreciation expense was $256 and $512 for the three and six months ended June 30, 2020, respectively. Accounts Payable Accounts payable consisted of the following: As of June 30, December 31, 2021 2020 Accounts payable — $ 14,031 $ 14,667 Accounts payable — 2,143 965 Total $ 16,174 $ 15,632 Accounts payable – Advertising reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients. Consolidated Statement of Operations and Comprehensive Loss Details Revenue Revenue for the periods presented were comprised of the following: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Advertising $ 9,969 $ 7,038 $ 20,296 $ 13,039 aiWARE SaaS Solutions 5,580 3,002 10,265 6,110 aiWARE Content Licensing and Media Services 3,657 3,228 6,940 6,023 Total revenue $ 19,206 $ 13,268 $ 37,501 $ 25,172 Other Expense, Net Other expense, net for the periods presented was comprised of the following: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Interest income, net $ 2 $ 5 $ 4 $ 82 Change in fair value of warrant liability — (202 ) — (200 ) Other (15 ) (38 ) (26 ) 14 Other expense, net $ (13 ) $ (235 ) $ (22 ) $ (104 )

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 7. COMMITMENTS AND CONTINGENCIES Leases The Company leases facilities under operating lease arrangements expiring on various dates through fiscal year 2024. Certain of the Company’s leases contain standard rent escalation and renewal clauses. Under certain leases, the Company is required to pay operating expenses in addition to base rent. Rent expense for lease payments is recognized on a straight-line basis over the lease term. In February 2021, the Company entered into an office sublease (the “Sublease”) with a third party (the “Subtenant”), pursuant to which the Company has subleased its former office space located in Costa Mesa, California, consisting of approximately 37,875 square feet, which the Company leases pursuant to an existing lease agreement expiring in 2024 (the “Lease”). The term of the Sublease commenced in March 2021 and will continue through December 31, 2024, coterminous with the Lease. Pursuant to the Sublease, the Subtenant will pay to the Company monthly base rent, which is subject to annual rent escalations, as well as a portion of the operating expenses and taxes payable by the Company under the Lease. The Company recognized contract termination costs as a liability when it ceased using the rights conveyed under the Lease. During the six months ended June 30, 2021, the Company recorded approximately $3,367 in charges resulting from the Sublease, consisting of $1,894 loss on disposal of property and equipment and leasehold improvements, As of June 30, 2021, future minimum lease payments were as follows: 2021 (six months) $ 1,087 2022 1,884 2023 1,685 2024 1,730 Total minimum payments $ 6,386 As of June 30, 2021, minimum sublease rental income to be received in the future under noncancelable subleases was approximately $3,970. The total rent expense for all operating leases, excluding the charges related to the Sublease discussed above, was $306 and $877 for the three and six months ended June 30, 2021, and $751 and $1,517 for the three and six months ended June 30, 2020, respectively. Sales Taxes The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes nexus exists, which therefore obligates the Company to collect and remit sales tax. During the three and six months ended June 30, 2021, the Company recorded a liability of $ and $284, respectively, for potential exposure in several states where there is uncertainty about the point in time at which the Company established a sufficient business connection to create nexus. As of June 30, 2021, the total accrued liability for potential sales tax exposure was $845. Other Contingencies From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company currently is not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations, financial position or cash flows.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Stockholders' Equity (Deficit)	NOTE 8. STOCKHOLDERS’ EQUITY (DEFICIT) Common Stock Issuances During the six months ended June 30, 2021 and 2020, the Company issued an aggregate of 803,367 shares of its common stock and 199,942 During the six months ended June 30, 2021, the Company issued a total of 167,495 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 84,723 shares of its common stock upon exercises of warrants to purchase an aggregate of 91,833 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price. During the six months ended June 30, 2020, the Company issued a total of 154,311 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,100. During the six months ended June 30, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company. During the six months ended June 30, 2020, the Company issued and sold an aggregate of 1,491,317 shares of its common stock pursuant to the Equity Distribution Agreement with JMH Securities (as sales agent) and received net proceeds from such sales of $6,006 after deducting expenses of $270. The Company voluntarily terminated the Equity Distribution Agreement in January 2021.

Stock Plans

Stock Plans	6 Months Ended
	Jun. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Plans	NOTE 9. STOCK PLANS Stock-Based Compensation During the six months ended June 30, 2021, the Company granted options to purchase an aggregate of 200,955 shares of its common stock that are subject to time-based vesting conditions. The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the six months ended June 30, 2021: Expected term (in years) 5.5 - 6.1 Expected volatility 82% - 83% Risk-free interest rate 0.6% - 1.0% Expected dividend yield — The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the six months ended June 30, 2021 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 101% - 119% Risk-free interest rate 0.1 % Expected dividend yield — The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Stock-based compensation expense by type of award: Restricted stock units $ 5,579 $ 753 $ 9,750 $ 895 Stock awards — 47 19 109 Performance-based stock options — 1,953 16,314 3,921 Stock options 798 1,306 1,635 3,455 Employee stock purchase plan 101 72 251 207 Common stock issued for services 131 — 250 - Total $ 6,609 $ 4,131 $ 28,219 $ 8,587 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 234 $ 198 $ 1,132 $ 376 Research and development 566 184 1,585 421 General and administrative 5,809 3,749 25,502 7,790 $ 6,609 $ 4,131 $ 28,219 $ 8,587 Equity Award Activity Under Stock Plans Stock Awards The Company’s stock award activity for the six months ended June 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 - $ - Granted 581 $ 32.33 Vested (581 ) $ 32.33 Unvested at June 30, 2021 - All stock awards granted during the six months ended June 30, 2021 were fully vested upon grant. As of June 30, 2021, there was no unrecognized compensation cost related to stock awards granted under the Company’s stock plans. Restricted Stock Units The Company’s restricted stock unit activity for the six months ended June 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 829,124 $ 11.53 Granted 394,020 $ 44.25 Forfeited (14,439 ) $ 39.60 Vested (749,374 ) $ 10.77 Unvested at June 30, 2021 459,331 $ 39.95 As of June 30, 2021, total unrecognized compensation cost related to restricted stock units was $11,705, which is expected to be recognized over a weighted average period of 0.8 year. Performance-Based Stock Options The activity during the six months ended June 30, 2021 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 4,234,020 $ 10.55 Exercised (273,159 ) $ 5.79 Forfeited (12,552 ) $ 5.92 Expired (3,588 ) $ 5.00 Outstanding at June 30, 2021 3,944,721 $ 10.90 7.02 years $ 34,750 Exercisable at June 30, 2021 3,944,721 $ 10.90 7.02 years $ 34,750 During the first six months of 2021, the Company achieved all of the stock price milestones applicable to substantially all of the performance-based stock options and, as a result, such performance-based stock options vested and all associated unrecognized compensation was accelerated and recognized in full as a one-time expense of $16,268 during the six months ended June 30, 2021. The aggregate intrinsic value of the options exercised during the six months ended June 30, 2021 was $6,517. No performance-based stock options were granted during six months ended June 30, 2021 and 2020, and no performance-based stock options vested during the six months ended June 30, 2020. Stock Options The activity during the six months ended June 30, 2021 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 5,400,070 $ 12.60 Granted 200,955 $ 33.11 Exercised (348,608 ) $ 8.78 Forfeited (104,774 ) $ 9.79 Expired (2,174 ) $ 5.33 Outstanding at June 30, 2021 5,145,469 $ 13.72 6.55 years $ 34,108 Exercisable at June 30, 2021 4,158,680 $ 13.81 6.05 years $ 24,674 The weighted average grant date fair value of stock options granted during the six months ended June 30, 2021 and 2020 was $23.09 and $2.06 per share, respectively. The aggregate intrinsic value of the stock options exercised during the six months ended June 30, 2021 and 2020 was $8,198 and $177 The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options. Employee Stock Purchase Plan During the six months ended June 30, 2021, a total of 67,068 shares of common stock were purchased under the Company’s ESPP. As of June 30, 2021, accrued employee contributions for future purchases under the ESPP totaled $223.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS On July 21, 2021, the Company entered into a definitive agreement to acquire Pandologic Ltd., a company incorporated under the laws of the state of Israel (“Pandologic”), pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) for total consideration of $150 million (the “Merger Consideration”). The Merger Consideration consists of upfront payments of $50 million in cash and $35 million in common stock (approximately 1.7 million shares) and $65 million payable based on earnouts tied to financial performance of Pandologic in fiscal 2021 and 2022, which amount will be paid in a combination of cash and common stock.

Presentation and Summary of S_2

Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation and Preparation	Basis of Presentation and Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 5, 2021. Interim results for the three and six months ended June 30, 2021 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2021. The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three and six month periods presented are unaudited. The December 31, 2020 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.
Reclassifications	Reclassifications Amortization expense, which was presented in prior year periods within cost of revenue, sales and marketing, research and development, and general and administrative operating expenses, has been reclassified and is presented as a single separate line item in operating expenses. Gross profit, which was previously reflected in the statement of operations and comprehensive loss, is no longer presented. Additionally, cost of revenue, which was presented in prior periods within gross profit, is now presented as an operating expense. The Company believes that this presentation more accurately reflects the Company’s cost of revenue and operating expenses. These reclassifications had no effect on reported net loss.
Liquidity and Capital Resources	Liquidity and Capital Resources During the years ended December 31, 2020 and 2019, the Company generated cash flows from operations of $1,433 and negative cash flows from operations of $30,432, respectively, and incurred net losses of $47,876 and $62,078, respectively. In the six months ended June 30, 2021, the Company generated negative cash flows from operations of $991 and incurred a net loss of $43,282. The Company expects to continue to generate net losses for the foreseeable future as it makes significant investments in developing and selling its aiWARE SaaS solutions. Management believes that the Company’s existing balances of cash and cash equivalents, which totaled $120,627 as of June 30, 2021, will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Such financing may not be available on terms favorable to the Company or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired.
Use of Accounting Estimates	Use of Accounting Estimates The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to revenue recognition, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of stock awards and stock warrants and income taxes, where applicable. There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.
Significant Customers	Significant Customers One individual customer accounted for 10% of the Company’s net revenues for the three months ended June 30, 2021. six months ended June 30, 2020 or the six months ended June 30, 2021.
Remaining Performance Obligations	Remaining Performance Obligations As of June 30, 2021, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $4,668, approximately 71% of which the Company expects to recognize as revenue over the next twelve months, and the remainder thereafter. This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations.
Significant Accounting Policies	Significant Accounting Policies There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2020.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption. In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes and early adoption is permitted

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Loss Per Common Share	The following table presents the computation of basic and diluted net loss per share: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Numerator Net loss $ (12,715 ) $ (11,793 ) $ (43,282 ) $ (24,477 ) Denominator Weighted-average common shares outstanding 32,756,357 27,135,107 32,475,448 26,964,717 Less: Weighted-average shares subject to repurchase (15,001 ) (17,675 ) (17,179 ) (19,420 ) Denominator for basic and diluted net loss per share attributable to common stockholders 32,741,356 27,117,432 32,458,269 26,945,297 Basic and diluted net loss per share $ (0.39 ) $ (0.43 ) $ (1.33 ) $ (0.91 )
Effect of Anti-dilutive Securities	The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Common stock options and restricted stock units 9,948,564 10,171,737 10,110,820 9,976,772 Warrants to purchase common stock 520,112 1,674,387 579,311 1,485,769 10,468,676 11,846,124 10,690,131 11,462,541

Financial Instruments (Tables)

Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2021
Investments All Other Investments [Abstract]
Schedule of Cash and Cash Equivalents	As of June 30, 2021, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 52,602 $ — $ 52,602 $ 52,602 Level 1: Money market funds 68,025 — 68,025 68,025 Total $ 120,627 $ — $ 120,627 $ 120,627 As of December 31, 2020, the Company’s cash and cash equivalents balances were as follows: Gross Cash and Unrealized Fair Cash Cost Losses Value Equivalents Cash $ 44,795 $ — $ 44,795 $ 44,795 Level 1: Money market funds 70,022 — 70,022 70,022 Total $ 114,817 $ — $ 114,817 $ 114,817

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	6 Months Ended
	Jun. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases	The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: June 30, 2021 December 31, 2020 Weighted Average Remaining Useful Life (in years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Software and technology 0.9 $ 3,582 $ (3,437 ) $ 145 $ 3,582 $ (3,357 ) $ 225 Licensed technology 0.3 500 (458 ) 42 500 (375 ) 125 Developed technology 2.2 9,600 (5,440 ) 4,160 9,600 (4,480 ) 5,120 Customer relationships 2.2 9,300 (5,270 ) 4,030 9,300 (4,340 ) 4,960 Noncompete agreements 1.1 800 (590 ) 210 800 (486 ) 314 Total 2.1 $ 23,782 $ (15,195 ) $ 8,587 $ 23,782 $ (13,038 ) $ 10,744
Summary of Future Amortization of Finite-Lived Intangible Assets	The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2021: 2021 (6 months) $ 2,104 2022 3,963 2023 2,520 Total $ 8,587

Consolidated Financial Statem_2

Consolidated Financial Statements Details (Tables)	6 Months Ended
	Jun. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Summary of Accounts Receivable, Net	Accounts receivable consisted of the following: As of June 30, December 31, 2021 2020 Accounts receivable — $ 15,380 $ 12,641 Accounts receivable — 4,221 4,143 19,601 16,784 Less: allowance for doubtful accounts (83 ) (118 ) Accounts receivable, net $ 19,518 $ 16,666
Summary of Property Equipment and Improvements, Net	Property, equipment and improvements, net consisted of the following: As of June 30, December 31, 2021 2020 Property and equipment $ 1,899 $ 2,365 Leasehold improvements 78 2,899 1,977 5,264 Less: accumulated depreciation (1,498 ) (2,910 ) Property, equipment and improvements, net $ 479 $ 2,354
Summary of Accounts Payable	Accounts payable consisted of the following: As of June 30, December 31, 2021 2020 Accounts payable — $ 14,031 $ 14,667 Accounts payable — 2,143 965 Total $ 16,174 $ 15,632
Summary of Revenue	Revenue for the periods presented were comprised of the following: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Advertising $ 9,969 $ 7,038 $ 20,296 $ 13,039 aiWARE SaaS Solutions 5,580 3,002 10,265 6,110 aiWARE Content Licensing and Media Services 3,657 3,228 6,940 6,023 Total revenue $ 19,206 $ 13,268 $ 37,501 $ 25,172
Schedule of Other Expense, Net	Other expense, net for the periods presented was comprised of the following: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Interest income, net $ 2 $ 5 $ 4 $ 82 Change in fair value of warrant liability — (202 ) — (200 ) Other (15 ) (38 ) (26 ) 14 Other expense, net $ (13 ) $ (235 ) $ (22 ) $ (104 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Summary of Future Minimum Lease Payments	As of June 30, 2021, future minimum lease payments were as follows: 2021 (six months) $ 1,087 2022 1,884 2023 1,685 2024 1,730 Total minimum payments $ 6,386

Stock Plans (Tables)

Stock Plans (Tables)	6 Months Ended
	Jun. 30, 2021
Schedule of Stock-based Compensation Expense	The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below: Three Months Ended Six Months Ended June 30, June 30, 2021 2020 2021 2020 Stock-based compensation expense by type of award: Restricted stock units $ 5,579 $ 753 $ 9,750 $ 895 Stock awards — 47 19 109 Performance-based stock options — 1,953 16,314 3,921 Stock options 798 1,306 1,635 3,455 Employee stock purchase plan 101 72 251 207 Common stock issued for services 131 — 250 - Total $ 6,609 $ 4,131 $ 28,219 $ 8,587 Stock-based compensation expense by operating expense grouping: Sales and marketing $ 234 $ 198 $ 1,132 $ 376 Research and development 566 184 1,585 421 General and administrative 5,809 3,749 25,502 7,790 $ 6,609 $ 4,131 $ 28,219 $ 8,587
Schedule of Stock Award Activity	The Company’s stock award activity for the six months ended June 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 - $ - Granted 581 $ 32.33 Vested (581 ) $ 32.33 Unvested at June 30, 2021 -
Schedule of Restricted Stock Unit Activity	The Company’s restricted stock unit activity for the six months ended June 30, 2021 was as follows: Weighted Average Grant Shares Date Fair Value Unvested at December 31, 2020 829,124 $ 11.53 Granted 394,020 $ 44.25 Forfeited (14,439 ) $ 39.60 Vested (749,374 ) $ 10.77 Unvested at June 30, 2021 459,331 $ 39.95
Schedule of Stock Option Activity	The activity during the six months ended June 30, 2021 related to all other stock options was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 5,400,070 $ 12.60 Granted 200,955 $ 33.11 Exercised (348,608 ) $ 8.78 Forfeited (104,774 ) $ 9.79 Expired (2,174 ) $ 5.33 Outstanding at June 30, 2021 5,145,469 $ 13.72 6.55 years $ 34,108 Exercisable at June 30, 2021 4,158,680 $ 13.81 6.05 years $ 24,674
Employee Stock Purchase Plan [Member]
Summary of Fair Value Assumptions of Stock Purchase Plan	The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the six months ended June 30, 2021 are set forth in the table below: Expected term (in years) 0.5 - 2.0 Expected volatility 101% - 119% Risk-free interest rate 0.1 % Expected dividend yield —
Stock Options [Member]
Schedule of Fair Value Assumptions	The following assumptions were used to compute the grant date fair values of the stock options granted during the six months ended June 30, 2021: Expected term (in years) 5.5 - 6.1 Expected volatility 82% - 83% Risk-free interest rate 0.6% - 1.0% Expected dividend yield —
Performance-based Stock Options [Member]
Schedule of Stock Option Activity	The activity during the six months ended June 30, 2021 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows: Weighted-Average Remaining Aggregate Exercise Contractual Intrinsic Options Price Term Value Outstanding at December 31, 2020 4,234,020 $ 10.55 Exercised (273,159 ) $ 5.79 Forfeited (12,552 ) $ 5.92 Expired (3,588 ) $ 5.00 Outstanding at June 30, 2021 3,944,721 $ 10.90 7.02 years $ 34,750 Exercisable at June 30, 2021 3,944,721 $ 10.90 7.02 years $ 34,750

Presentation and Summary of S_3

Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021USD ($)Customer	Jun. 30, 2020USD ($)Customer	Jun. 30, 2021USD ($)Customer	Jun. 30, 2020USD ($)Customer	Dec. 31, 2020USD ($)Customer	Dec. 31, 2019USD ($)
Significant Accounting Policies [Line Items]
Positive (negative) cash flows from operations			$ (991)	$ (2,777)	$ 1,433	$ (30,432)
Net loss	$ 12,715	$ 11,793	43,282	24,477	47,876	$ 62,078
Accumulated deficit	323,647		323,647		280,365
Net proceeds from sales of common stock from the period					59,771
Proceeds from issuances of stock under employee stock plans, net			4,794	140
Net proceeds from sales of common stock				6,527
Proceeds from the exercise of warrants			2,279	$ 2,100
Cash and cash equivalents	120,627		120,627		$ 114,817
Transaction price remaining performance obligations	$ 4,668		$ 4,668
Transaction price remaining performance obligations percentage	71.00%		71.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer	1	1	0	0
Concentration risk percentage	10.00%	11.00%	10.00%	10.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer				2	2
Concentration risk percentage				10.00%	10.00%
Equity Distribution Agreement [Member]
Significant Accounting Policies [Line Items]
Net proceeds from sales of common stock					$ 5,986

Presentation and Summary of S_4

Presentation and Summary of Significant Accounting Policies - Additional Information (Details 1)	Jun. 30, 2021
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-07-01
Significant Accounting Policies [Line Items]
Expected Recognition of revenue over remaining contract terms	12 months

Net Income Loss Per Share - Com

Net Income Loss Per Share - Computation of Basic and Diluted Net Loss Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Numerator
Net loss	$ (12,715)	$ (11,793)	$ (43,282)	$ (24,477)	$ (47,876)	$ (62,078)
Denominator
Weighted-average common shares outstanding	32,756,357	27,135,107	32,475,448	26,964,717
Less: Weighted-average shares subject to repurchase	(15,001)	(17,675)	(17,179)	(19,420)
Denominator for basic and diluted net loss per share attributable to common stockholders	32,741,356	27,117,432	32,458,269	26,945,297
Basic and diluted net loss per share	$ (0.39)	$ (0.43)	$ (1.33)	$ (0.91)

Net Income Loss Per Share - Eff

Net Income Loss Per Share - Effect of Anti-dilutive Securities (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	10,468,676	11,846,124	10,690,131	11,462,541
Employee Stock Option and Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	9,948,564	10,171,737	10,110,820	9,976,772
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	520,112	1,674,387	579,311	1,485,769

Financial Instruments - Schedul

Financial Instruments - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Schedule Of Available For Sale Securities [Line Items]
Total Cash and Debt Securities	$ 120,627	$ 114,817
Total Fair Value, Cash and Debt Securities	120,627	114,817
Cash and cash equivalents	120,627	114,817
Cash [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	52,602	44,795
Fair Value, Cash	52,602	44,795
Level 1 [Member] | Money Market Funds [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	68,025	70,022
Cash and cash equivalents gross before unrealized losses	68,025	70,022
Fair Value, Cash	$ 68,025	$ 70,022

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Carrying amount of goodwill	$ 6,904	$ 6,904

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net - Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases (Detail) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	2 years 1 month 6 days
Gross Carrying Amount	$ 23,782	$ 23,782
Accumulated Amortization	(15,195)	(13,038)
Net Carrying Amount	$ 8,587	10,744
Software and Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	10 months 24 days
Gross Carrying Amount	$ 3,582	3,582
Accumulated Amortization	(3,437)	(3,357)
Net Carrying Amount	$ 145	225
Licensed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 months 18 days
Gross Carrying Amount	$ 500	500
Accumulated Amortization	(458)	(375)
Net Carrying Amount	$ 42	125
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	2 years 2 months 12 days
Gross Carrying Amount	$ 9,600	9,600
Accumulated Amortization	(5,440)	(4,480)
Net Carrying Amount	$ 4,160	5,120
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	2 years 2 months 12 days
Gross Carrying Amount	$ 9,300	9,300
Accumulated Amortization	(5,270)	(4,340)
Net Carrying Amount	$ 4,030	4,960
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	1 year 1 month 6 days
Gross Carrying Amount	$ 800	800
Accumulated Amortization	(590)	(486)
Net Carrying Amount	$ 210	$ 314

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net - Summary of Future Amortization of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2021 (6 months)	$ 2,104
2022	3,963
2023	2,520
Net Carrying Amount	$ 8,587	$ 10,744

Consolidated Financial Statem_3

Consolidated Financial Statements Details - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 120,627		$ 120,627		$ 114,817
Write-off of property and equipment and leasehold improvements			3,559
Loss on disposal			1,894
Depreciation Expense	78	$ 256	253	$ 512
Advertising Clients and Content Licensees [Member]
Condensed Financial Statements, Captions [Line Items]
Cash received	$ 48,226		$ 48,226		$ 40,052
Advertising [Member]
Condensed Financial Statements, Captions [Line Items]
Percentage of average commission earned on amount invoiced and collected			15.00%

Consolidated Financial Statem_4

Consolidated Financial Statements Details - Summary of Accounts Receivable,Net (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Accounts receivable, gross	$ 19,601	$ 16,784
Less: allowance for doubtful accounts	(83)	(118)
Accounts receivable, net	19,518	16,666
Advertising [Member]
Accounts receivable, gross	15,380	12,641
Other [Member]
Accounts receivable, gross	$ 4,221	$ 4,143

Consolidated Financial Statem_5

Consolidated Financial Statements Details - Summary of Property Equipment and Improvements, Net (Detail) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Property Plant And Equipment [Abstract]
Property and equipment	$ 1,899	$ 2,365
Leasehold improvements	78	2,899
Property, equipment and improvements, gross	1,977	5,264
Less: accumulated depreciation	(1,498)	(2,910)
Property, equipment and improvements, net	$ 479	$ 2,354

Consolidated Financial Statem_6

Consolidated Financial Statements Details - Accounts Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Statement Of Financial Position [Abstract]
Accounts payable — Advertising	$ 14,031	$ 14,667
Accounts payable — Other	2,143	965
Total	$ 16,174	$ 15,632

Consolidated Financial Statem_7

Consolidated Financial Statements Details - Summary of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 19,206	$ 13,268	$ 37,501	$ 25,172
Advertising [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	9,969	7,038	20,296	13,039
aiWARE SaaS Solutions [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	5,580	3,002	10,265	6,110
aiWARE Content Licensing and Media Services [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 3,657	$ 3,228	$ 6,940	$ 6,023

Consolidated Financial Statem_8

Consolidated Financial Statements Details - Schedule of Other Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Other Income And Expenses [Abstract]
Interest income, net	$ 2	$ 5	$ 4	$ 82
Change in fair value of warrant liability		(202)		(200)
Other	(15)	(38)	(26)	14
Other expense, net	$ (13)	$ (235)	$ (22)	$ (104)

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 28, 2021ft²	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2020USD ($)
Other Commitments [Line Items]
Loss on disposal of property and equipment and leasehold improvements				$ (1,894)
Loss on sublease				1,211
Minimum sublease rental income to be received in the future under noncancelable subleases		$ 3,970		3,970
Rent expense		306	$ 751	877	$ 1,517
Liability for potential exposure		146		284
Total accrued liability for potential sales tax		$ 845		845
Office Sublease [Member]
Other Commitments [Line Items]
Area of Office Space Subleased | ft²	37,875
Lease Expiration Date	Dec. 31, 2024
Sublease charges				3,367
Loss on disposal of property and equipment and leasehold improvements				(1,894)
Loss on sublease				1,211
Initial direct costs				$ 262

Commitments and Contingencies_2

Commitments and Contingencies - Summary of Future Minimum Lease Payments (Detail) - Building Lease Agreement [Member] $ in Thousands	Jun. 30, 2021USD ($)
Other Commitments [Line Items]
2021 (six months)	$ 1,087
2022	1,884
2023	1,685
2024	1,730
Total minimum payments	$ 6,386

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Class Of Stock [Line Items]
Net proceeds from stock issuance			$ 6,527
Exercise of warrants	$ 2,100	$ 2,279	2,100
JMP Securities [Member]
Class Of Stock [Line Items]
Net proceeds from stock issuance			$ 6,006
Common Stock
Class Of Stock [Line Items]
Shares issued to outside service provider, shares		15,828
Common stock shares issued	199,109		1,491,317
Exercise of warrants		$ 2,279	$ 2,100
Exercise of warrants issued, shares for cash consideration		167,495	154,311
Aggregate exercise of warrants issued, shares		84,723
Issued warrants to purchase shares upon exercises		91,833
Common Stock | JMP Securities [Member]
Class Of Stock [Line Items]
Common stock shares issued			1,491,317
Stock issuance costs			$ 270
Common Stock and Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Shares issued in connection with stock option exercise		803,367	199,942

Stock Plans - Additional Inform

Stock Plans - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Common stock were purchased under ESPP	67,068
Accrued employee contributions	$ 223,000
Timebased Stock Option [Member]
Class Of Stock [Line Items]
Options granted	200,955
Stock Awards [Member]
Class Of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 0
Restricted Stock Units [Member]
Class Of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 11,705,000
Cost of share-based compensation awards, recognition period	9 months 18 days
Performance-based Stock Options [Member]
Class Of Stock [Line Items]
Total grant date fair value of stock options granted	$ 0	$ 0
Total grant date fair value of stock options vested		0
Unrecognized compensation expense related to stock options	16,268,000
Aggregate intrinsic value of the options exercised	$ 6,517,000	0
Stock Options [Member]
Class Of Stock [Line Items]
Options granted	200,955
Cost of share-based compensation awards, recognition period	3 years
Total grant date fair value of stock options vested	$ 1,313,000	4,067,000
Unrecognized compensation expense related to stock options	8,137,000
Aggregate intrinsic value of the options exercised	$ 8,198,000	$ 177,000
Weighted Average Grant Date Fair Value, Granted	$ 23.09	$ 2.06

Stock Plans - Schedule of Fair

Stock Plans - Schedule of Fair Value Assumptions (Detail) - Stock Options [Member]	6 Months Ended
	Jun. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	82.00%
Expected volatility, maximum	83.00%
Risk-free interest rate, minimum	0.60%
Risk-free interest rate, maximum	1.00%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	5 years 6 months
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 years 1 month 6 days

Stock Plans - Summary of Fair V

Stock Plans - Summary of Fair Value Assumptions of Stock Purchase Plan (Detail) - Employee Stock Purchase Plan [Member]	6 Months Ended
	Jun. 30, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	101.00%
Expected volatility, maximum	119.00%
Risk-free interest rate	0.10%
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 months
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	2 years

Stock Plans - Schedule of Stock

Stock Plans - Schedule of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 6,609	$ 4,131	$ 28,219	$ 8,587
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	234	198	1,132	376
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	566	184	1,585	421
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	5,809	3,749	25,502	7,790
Restricted Stock Units [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	5,579	753	9,750	895
Stock Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		47	19	109
Performance-based Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		1,953	16,314	3,921
Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	798	1,306	1,635	3,455
Common Stock Issued for Services [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	131		250
Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 101	$ 72	$ 251	$ 207

Stock Plans - Schedule of Sto_2

Stock Plans - Schedule of Stock Award Activity (Detail) - Stock Awards [Member]	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Granted | shares	581
Shares, Vested | shares	(581)
Weighted Average Grant Date Fair Value, Granted | $ / shares	$ 32.33
Weighted Average Grant Date Fair Value, Vested | $ / shares	$ 32.33

Stock Plans - Schedule of Restr

Stock Plans - Schedule of Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member]	6 Months Ended
	Jun. 30, 2021$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Unvested, Beginning Balance | shares	829,124
Shares, Granted | shares	394,020
Shares, Forfeited | shares	(14,439)
Shares, Vested | shares	(749,374)
Shares, Unvested, Ending Balance | shares	459,331
Weighted Average Grant Date Fair Value, Unvested, Beginning Balance | $ / shares	$ 11.53
Weighted Average Grant Date Fair Value, Granted | $ / shares	44.25
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	39.60
Weighted Average Grant Date Fair Value, Vested | $ / shares	10.77
Weighted Average Grant Date Fair Value, Unvested, Ending Balance | $ / shares	$ 39.95

Stock Plans - Schedule of Perfo

Stock Plans - Schedule of Performance-Based Stock Options Activity (Detail) - Performance-based Stock Options [Member] $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	4,234,020
Options Exercised | shares	(273,159)
Options Forfeited | shares	(12,552)
Options Expired | shares	(3,588)
Options, Outstanding, Ending Balance | shares	3,944,721
Options Exercisable at March 31, 2021 | shares	3,944,721
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 10.55
Weighted-Average Exercise Price, Options Exercised | $ / shares	5.79
Weighted-Average Exercise Price, Options Forfeited | $ / shares	5.92
Weighted-Average Exercise Price, Options Expired | $ / shares	5
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	10.90
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 10.90
Weighted-Average Remaining Contractual Term, Outstanding	7 years 7 days
Weighted-Average Remaining Exercisable	7 years 7 days
Weighted-Average Aggregate Intrinsic Value | $	$ 34,750
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 34,750

Stock Plans - Schedule of Sto_3

Stock Plans - Schedule of Stock Option Activity (Detail) - Stock Options [Member] $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2021USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	5,400,070
Options Granted | shares	200,955
Options Exercised | shares	(348,608)
Options Forfeited | shares	(104,774)
Options Expired | shares	(2,174)
Options, Outstanding, Ending Balance | shares	5,145,469
Options Exercisable at March 31, 2021 | shares	4,158,680
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 12.60
Weighted-Average Exercise Price, Options Granted | $ / shares	33.11
Weighted-Average Exercise Price, Options Exercised | $ / shares	8.78
Weighted-Average Exercise Price, Options Forfeited | $ / shares	9.79
Weighted-Average Exercise Price, Options Expired | $ / shares	5.33
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	13.72
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 13.81
Weighted-Average Remaining Contractual Term, Outstanding	6 years 6 months 18 days
Weighted-Average Remaining Exercisable	6 years 18 days
Weighted-Average Aggregate Intrinsic Value | $	$ 34,108
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 24,674

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Subsequent Event - Merger Agreement [Member] - Pandologic Ltd [Member] shares in Millions, $ in Millions	Jul. 21, 2021USD ($)shares
Subsequent Event [Line Items]
Total consideration	$ 150
Merger consideration upfront payment in cash	50
Merger, earnout consideration payable	65
Common Stock
Subsequent Event [Line Items]
Merger consideration transferred equity interests issued	$ 35
Merger consideration equity interest issued number of shares | shares	1.7